Skip to main content
Livermore
Livermore
ZHEN

Gabelli Funds LLC

SEC CIK
0001081407
Latest filing
Aug 12, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Gabelli Funds LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
17,300
Value
$989.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMRN by Gabelli Funds LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,300$989.9K<0.1%00.0%UnchangedHolders
Q1 202617,300$977.3K<0.1%00.0%UnchangedHolders
Q4 202517,300$1.03M<0.1%−12,500−41.9%ReducedHolders
Q3 202529,800$1.61M<0.1%+6,000+25.2%AddedHolders
Q2 202523,800$1.31M<0.1%+7,000+41.7%AddedHolders
Q1 202516,800$1.19M<0.1%−3,539−17.4%ReducedHolders
Q4 202420,339$1.34M<0.1%+7,500+58.4%AddedHolders
Q3 202412,839$902.5K<0.1%+4,800+59.7%AddedHolders
Q2 20248,039$661.9K<0.1%+1,114+16.1%AddedHolders
Q1 20246,925$604.8K<0.1%−250−3.5%ReducedHolders
Q4 20237,175$691.8K<0.1%−1,030−12.6%ReducedHolders
Q3 20238,205$726.0K<0.1%−500−5.7%ReducedHolders
Q2 20238,705$754.5K<0.1%−85−1.0%ReducedHolders
Q1 20238,790$854.7K<0.1%+255+3.0%AddedHolders
Q4 20228,535$883.3K<0.1%−10,085−54.2%ReducedHolders
Q3 202218,620$1.58M<0.1%+250+1.4%AddedHolders
Q2 202218,370$1.52M<0.1%+750+4.3%AddedHolders
Q1 202217,620$1.36M<0.1%−2,620−12.9%ReducedHolders
Q4 202120,240$1.79M<0.1%−13,740−40.4%ReducedHolders
Q3 202133,980$2.63M<0.1%+60+0.2%AddedHolders
Q2 202133,920$2.83M<0.1%−750−2.2%ReducedHolders
Q1 202134,670$2.62M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.